NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.3331TPS613#Background:Approximately 50% of newly diagnosed breast cancers are stage 1, with the majority ...